Haemostasis and the Need for Antithrombotics: An Introduction

Area of Science:

• Pharmacology
• Cardiovascular Medicine
• Public Health

Background:

• Antithrombotic and antiplatelet agents have a long history, with many recognized as essential medicines by the WHO.
• Global mortality and morbidity from cardiovascular diseases and thrombosis are rising.
• Legacy drugs (heparin, warfarin) and newer agents (DOACs, antiplatelets) are critical for public health.

Purpose of the Study:

• To provide a framework for understanding antithrombotic and antiplatelet therapies.
• To highlight the importance of these agents in managing thrombotic diseases.
• To set the stage for discussing new developments and monitoring requirements.

Main Methods:

• This section is a chapter introduction, setting the context for the book.
• It reviews the historical and current landscape of antithrombotic and antiplatelet agents.
• It emphasizes the growing need for these therapies due to increasing disease prevalence.

Main Results:

• The abstract does not present specific results but rather outlines the scope of the book.
• It indicates that new therapies are continuously being developed.
• It stresses the necessity of monitoring these therapies for safety and efficacy.

Conclusions:

• Antithrombotic and antiplatelet agents are indispensable for global health.
• Ongoing research and development are essential for addressing thrombotic diseases.
• Effective monitoring is crucial for the safe and efficient use of these vital medications.